Research Priorities for the Common HIV-Related Respiratory Infections

  • Adam S. Malin
  • Keith P. W. J. McAdam


Pneumocystis carinii pneumonia (PCP) is the major respiratory pathogen affecting HIV-infected individuals in the industrialized world. Clear advances have been made in prevention and treatment. This has resulted in a reduction in disease incidence and morbidity. Co-trimoxazole is still the drug of choice for prophylaxis and treatment. However, drug toxicity is a serious problem and the alternatives available, although of lower toxicity, are less efficacious. Thus, the search for an alternative agent is of key importance.


Acquire Immune Deficiency Syndrome Pneumocystis CARINII Pneumonia Pneumococcal Disease Acquire Immune Deficiency Syndrome Patient Aerosolized Pentamidine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abouya, Y.L., Beaumel, A., Lucas, S. et al. (1992) Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Am. Rev. Respir. Dis., 145, 617–20.Google Scholar
  2. Atzori, C., Bruno, A., Chichino, G. et al. (1993) Pneumocystis carinii pneumonia and tuberculosis in Tanzanian patients infected with HIV. Trans. R. Soc. Trop. Med. Hyg, 87, 55–6.CrossRefGoogle Scholar
  3. Bennett, D., Watson, J. (1994) Tuberculosis in the immunocompetent patient. Curr. Op. Infect. Dis., 7, 184–91.CrossRefGoogle Scholar
  4. Benson, C.A. (1994) Mycobacterium tuberculosis and Mycobacterium avium complex disease in patients with HIV infection. Curr. Op. Infect. Dis., 7, 95–107.Google Scholar
  5. Blum, R.N., Miller, L.A., Gaggini, L.C. et al. (1992) Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. J. Acquir. Imm. Defic. Syndr., 5, 341–7.Google Scholar
  6. Brindle, R. (1992) Aspects of tuberculosis in Africa. 2. The value of microbiology in the management of tuberculosis in Nairobi, Kenya. Trans. R. Soc. Trop. Med. Hyg., 86, 470–1.PubMedCrossRefGoogle Scholar
  7. Butler, J.C., Breiman, R.F., Campbell, J.F. et al. (1993) Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. DAMA, 270, 1826–31.CrossRefGoogle Scholar
  8. Centers for Disease Control (1993) Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR. Morb. Mortal Wkly. Rep., 42, 1–8.Google Scholar
  9. Chintu, C., Luo, C., Bhat, G. et al. (1993) Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I. Arch. Dis. Child, 68, 665–8.PubMedCrossRefGoogle Scholar
  10. Clarridge, J.E.I., Shawar, R.M., Shinnick, T.M. et al. (1993) Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J. Clin. Microbiol., 31, 2049–56.PubMedGoogle Scholar
  11. Daley, C.L. (1994) Pulmonary infections in the tropics: impact of HIV infection. Thorax, 49, 370–8.PubMedCrossRefGoogle Scholar
  12. Daley, C.L., Small, P.M., Schecter, G.F. et al. (1992) An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N. Engl. J. Med., 326, 231–5.PubMedCrossRefGoogle Scholar
  13. Decker, C.F., Masur, H. (1994) Current status of prophylaxis for opportunistic infections in HIV-infected patients. AIDS, 8, 11–20.PubMedCrossRefGoogle Scholar
  14. Dolin, P.J., Raviglione, M.C. and Kochi, A. (1994) Global tuberculosis incidence and mortality during 1990–2000. Bull. World Health Organ., 72, 213–20.PubMedGoogle Scholar
  15. Elliott, A.M., Hayes, R.J., Halwündi, B. et al. (1993) The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS, 7, 981–7.PubMedCrossRefGoogle Scholar
  16. Flynn, J.L., Goldstein, M.M., Triebold, K.J. et al. (1992) Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA, 89, 12013–17.PubMedCrossRefGoogle Scholar
  17. Forte, M., Maartens, G., Rahelu, M. et al. (1992) Cytolytic T-cell activity against mycobacterial antigens in HIV. AIDS, 6, 407–11.PubMedCrossRefGoogle Scholar
  18. Gilks, C. (1993) Pneumococcal disease and HIV infection. Ann. Intern. Med., 118, 393.PubMedCrossRefGoogle Scholar
  19. Girard, P.M. and Feinberg, J. (1994) Progress and problems in AIDS-associated opportunistic infections. AIDS, 8, S249–S259.Google Scholar
  20. Hill, A.V., Allsopp, C.E., Kwiatkowski, D. et al. (1991) Common West African HLA antigens are associated with protection from severe malaria (see comments). Nature, 352, 595–600.PubMedCrossRefGoogle Scholar
  21. Hopewell, P.C. (1992) Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin. Infect. Dis., 15, 540–47.PubMedCrossRefGoogle Scholar
  22. Hughes, W., Leoung, G., Kramer, F. et al. (1993) Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med., 328, 1521–7.PubMedCrossRefGoogle Scholar
  23. Iseman, M.D. (1993) Treatment of multidrugresistant tuberculosis. N. Engl. J Med., 329, 784–91.PubMedCrossRefGoogle Scholar
  24. Jacobs Jr, W.R., Barletta, R.G., Udani, R. et al. (1993) Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages (see comments). Science, 260, 819–22.PubMedCrossRefGoogle Scholar
  25. Kaufmann, S.H.E. (1993) Immunity to intracellular bacteria. Annu. Rev. Immunol., 11, 129–63.PubMedCrossRefGoogle Scholar
  26. Kent, R.J., Uttley, A.H., Stoker, N.G. et al. (1994) Transmission of tuberculosis in British centre for patients infected with HIV. Br. Med. J., 309, 639–40.CrossRefGoogle Scholar
  27. Kochi, A., Vareldzis, B., and Styblo, K. (1993) Multidrug-resistant tuberculosis and its control. Res. Microbiol., 144, 104–10.PubMedCrossRefGoogle Scholar
  28. Koornhof, H.J., Wasas, A. and Klugman, K. (1992) Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clin. Infect. Dis., 15, 84–94.PubMedCrossRefGoogle Scholar
  29. Machiels, G. and Urban, M.I. (1992) Pneumocystis carinii as a cause of pneumonia in HIV-infected patients in Lusaka, Zambia. Trans. R. Soc. Trop. Med. Hyg., 86, 399–400.CrossRefGoogle Scholar
  30. Masur, H. (1992) Prevention and treatment of pneumocystis pneumonia (published erratum appears in N. Engl J. Med 1993 Apr 15;328(15):1136). N. Engl. J. Med., 327, 185360.Google Scholar
  31. McDougal, L.K., Facklam, R., Reeves, M et al. (1992) Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob. Agents Chemother., 36, 2176–84.PubMedCrossRefGoogle Scholar
  32. Montaner, J. S., Guillemi, S., Quieffin, J. et al. (1993) Oral corticosteroids in patients with mild Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome (AIDS). Tuber. Lung Dis., 74, 173–9.PubMedCrossRefGoogle Scholar
  33. Moreno, S., Baraia Etxaburu, J., Bouza, E. et al. (1993) Risk for developing tuberculosis among anergic patients infected with HIV (see comments). Ann. Intern. Med., 119, 194–8.PubMedCrossRefGoogle Scholar
  34. Mufson, M.A. (1994) Pneumococcal infection. Curr. Op. Infect. Dis., 7, 178–83.CrossRefGoogle Scholar
  35. Narain, J.P., Raviglione, M.C. and Kochi, A. (1992) HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber. Lung Dis., 73, 311–21.PubMedCrossRefGoogle Scholar
  36. Nunn, P.P., Elliott, A.M. and McAdam, K.P.W.J. (1994) Impact of human immunodeficiency virus on tuberculosis in developing countries. Thorax, 49, 511–18.PubMedCrossRefGoogle Scholar
  37. Orme, I.M., Andersen, P. and Boom, W.H. (1993) T cell response to Mycobacterium tuberculosis. J. Infect. Dis., 167, 1481–7.CrossRefGoogle Scholar
  38. Pape, J.W., Jean, S.S., Ho, J.L. et al. (1993) Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet, 342, 268–72.PubMedCrossRefGoogle Scholar
  39. Peeters, C.C., Tenbergen Meekes, A.M., Pool-man, J.T. et al. (1992) Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide—protein conjugate vaccine is decreased by admixture of high doses of free saccharide. Vaccine, 10, 833–40.PubMedCrossRefGoogle Scholar
  40. Piot, P., Kapita, B.M., Ngugi, E.N. et al. (1992) Aids in Africa: a manual for physicians. World Health Organization, Geneva, pp. 87.Google Scholar
  41. Ponnighaus, J.M., Fine, P.E., Sterne, J.A. et al. (1992) Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi (see comments). Lancet, 339, 636–9.PubMedCrossRefGoogle Scholar
  42. Raviglione, M.C., Narain, J.P. and Kochi, A. (1992) HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment. Bull. World Health Organ., 70, 51526.Google Scholar
  43. Redd, S.C., Rutherford, G.W., Sande, M.A. et al. (1990) The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J. Infect. Dis., 162, 1012–7.PubMedCrossRefGoogle Scholar
  44. Reichman, L.B. (1989) Why hasn’t BCG proved dangerous in HIV-infected patients? (letter) (see comments). JAMA, 261, 3246.PubMedCrossRefGoogle Scholar
  45. Rook, G.A.W., Hernandez-Pando, R. and Lightman, S.L. (1994) Hormones, peripherally activated prohormones and regulation of the Thl/Th2 balance. Immunol. Today, 15, 301–3.PubMedCrossRefGoogle Scholar
  46. Rook, G.A. and al Attiyah, R. (1991) Cytokines and the Koch phenomenon. Tubercle, 72, 1320.Google Scholar
  47. Rook, G.A., Onyebujoh, P. and Stanford, J.L. (1993) TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV (letter). Immunol. Today, 14, 568–9.PubMedCrossRefGoogle Scholar
  48. Rook, G.A., Steele, J., Ainsworth, M. et al. (1986) Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology, 59, 333–8.PubMedGoogle Scholar
  49. Saceanu, C.A., Pfeiffer, N.C. and McLean, T. (1993) Evaluation of sputum smears concentrated by cytocentrifugation for detection of acid-fast bacilli. J. Clin. Microbiol., 31, 2371–4.PubMedGoogle Scholar
  50. Safrin, A., Finkelstein, D.M., Feinberg, J. et al. (1996) Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. Ann. Intern. Med.,124, 9, 792–802.Google Scholar
  51. Schneider, M.M., Hoepelman, A.I., Eeftinck Schattenkerk, J.K. et al. (1992) A controlled trial of aerosolized pentamidine or trimethoprimsulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group (see comments). N. Engl. J. Med., 327, 1836–41.PubMedCrossRefGoogle Scholar
  52. Schulzer, M., Fitzgerald, J.M., Enarson, D.A. et al. (1992) An estimate of the future size of the tuberculosis problem in Sub-Saharan Africa resulting from HIV infection (published erratum appears in Tuber. Lung Dis., 1992 Aug; 73 (4): 2456 ).Google Scholar
  53. Schulzer, M., Fitzgerald, J.M., Enarson, D.A. et al. (1992) An estimate of the future size of the tuberculosis problem in Sub-Saharan Africa resulting from HIV infection (published erratum appears in Tuber. Lung Dis., 73, 52–8.PubMedCrossRefGoogle Scholar
  54. Silva, C.L. and Lowrie, D.B. (1994) A single mycobacterial protein (hsp 65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis. Immunology, 82, 2448.Google Scholar
  55. Sleasman, J.W., Hemenway, C., Klein, A.S. et al. (1993) Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. Am. J. Dis. Child, 147, 30–4.PubMedGoogle Scholar
  56. Soeiro, R. and Segal-Maurer, S. (1994) Tuberculosis: nosocomial transmission and control of infection. AIDS, 8, S239 — S247.CrossRefGoogle Scholar
  57. Stanford, J.L. and Grange, J.M. (1993) New concepts for the control of tuberculosis in the twenty first century. J. R. Coll. Phys. Lond., 27, 218–23.Google Scholar
  58. Stanford, J.L., Rook, G.A., Bahr, G. et al. (1990) Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine, 8, 525–30.Google Scholar
  59. Toossi, Z., Sierra Madero, J.G., Blinkhorn, R.A. et al. (1993) Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J. Exp. Med., 177, 1511–6.PubMedCrossRefGoogle Scholar
  60. van Soolingen, D., de Haas, P.E., Hermans, P.W. et al. (1993) Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J. Clin. Microbiol., 31, 1987–95.Google Scholar
  61. Vareldzis, B.P., Grosset, J., de Kantor, et al. (1994) Drug-resistant tuberculosis: laboratory issues. Tuber. Lung Dis., 75, 1–7.PubMedCrossRefGoogle Scholar
  62. Vella, P.P., Marburg, S., Staub, J.M. et al. (1992) Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex. Infect. Immun., 60, 4977–83.PubMedGoogle Scholar
  63. Wallis, R.S., Vjecha, M., Amir Tahmasseb, M. et al. (1993) Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2microglobulin in HIV-1–associated tuberculosis. J. Infect. Dis., 167, 43–8.PubMedCrossRefGoogle Scholar
  64. Weltman, A.C. and Rose, D.N. (1993) The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS (editorial). AIDS, 7, 14957.CrossRefGoogle Scholar
  65. Wilkinson, D. (1994) High-compliance tuberculosis treatment programme in a rural community. Lancet, 343, 647–8.PubMedCrossRefGoogle Scholar
  66. WHO (1995) Tuberculosis and HIV Research: working Towards Solutions. WHO/TB/95, 193.Google Scholar
  67. Wilson, S.M., McNerney, R., Nye, P.M. et al. (1993) Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J. Clin. Microbiol., 31, 776–82.PubMedGoogle Scholar
  68. Zhang, Y., Lathigra, R., Garbe, T. et al. (1991) Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis. Mol. Microbiol., 5, 381–91.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1997

Authors and Affiliations

  • Adam S. Malin
  • Keith P. W. J. McAdam

There are no affiliations available

Personalised recommendations